Home › Cancro alla prostata › South Carolina
Studi clinici su Cancro alla prostata nello stato di South Carolina
42 studi su Cancro alla prostata cercano partecipanti presso sedi nello stato di South Carolina.
Città nello stato di South Carolina
- Myrtle Beach23 studi
- Charleston15 studi
- Greenville7 studi
- Greer5 studi
- Spartanburg5 studi
- Florence3 studi
Testo ufficiale dello studio (inglese)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Saint Francis Hospital, Greenville
- Saint Francis Cancer Center, Greenville
- Self Regional Healthcare, Greenwood
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 2 ott 2026 · NCT06931340Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- AnMed Health Cancer Center, Anderson
- Prisma Health Richland Hospital, Columbia
- McLeod Regional Medical Center, Florence
- e altri 12
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Gibbs Cancer Center-Gaffney, Gaffney
- Gibbs Cancer Center-Pelham, Greer
- Spartanburg Medical Center, Spartanburg
- e altri 1
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Medical University of South Carolina, Charleston
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT03866382Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
- Carolina Urologic Research Center, Myrtle Beach
In reclutamentoStudio osservazionale
Età da 40 a 75 · Uomini · Aggiornato il 28 set 2026 · NCT07543757Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Research Site, Myrtle Beach
In reclutamentoFase 1/2
Età da 18 a 130 · Uomini · Aggiornato il 25 set 2026 · NCT07181161Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
In reclutamentoFase 1/2
Età 18 e oltre · Uomini · Aggiornato il 25 set 2026 · NCT06800313Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 25 set 2026 · NCT06801236A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Ralph H. Johnson VA Health Care System (RHJVAHCS)-Urology ( Site 0083), Charleston
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06136650This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Grand Strand Medical Center, Myrtle Beach
- Carolina Urologic Research Center, LLC, Myrtle Beach
- Parkway Surgery Center, Myrtle Beach
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 24 set 2026 · NCT07028853A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- START Carolinas, Myrtle Beach
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 24 set 2026 · NCT07719361Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Carolina Urologic Research Center, Myrtle Beach
In reclutamentoFase 2/3
Età da 18 a 100 · Uomini · Aggiornato il 22 set 2026 · NCT06780670A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- South Texas Accelerated Research Therapeutics - Carolinas, Myrtle Beach
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 22 set 2026 · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- MUSC Hollings Cancer Center, Charleston
- Carolina Urologic Research Center, Myrtle Beach
In reclutamentoFase 3
Età da 18 a 100 · Uomini · Aggiornato il 22 set 2026 · NCT06855277A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Myrtle Beach
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 18 set 2026 · NCT06952803High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 17 set 2026 · NCT05011383A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
- START Carolinas, Myrtle Beach
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 15 set 2026 · NCT07332000Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Lowcountry Urology Clinics, North Charleston
In reclutamento
Età 18 e oltre · Uomini · Aggiornato il 14 set 2026 · NCT06511141Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Carolina Urologic Research Center, Myrtle Beach
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 11 set 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- McLeod Regional Medical Center, Florence
- Gibbs Cancer Center-Gaffney, Gaffney
- Self Regional Healthcare, Greenwood
- e altri 3
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 10 set 2026 · NCT05946213Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
- Medical University of South Carolina - Hollings Cancer Center, Charleston
- Prisma Health Cancer Institute, Greenville
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 3 set 2026 · NCT07545811A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 3 set 2026 · NCT07005154AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Myrtle Beach
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 26 ago 2026 · NCT07611110A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 25 ago 2026 · NCT05593497Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Medical University of South Carolina, Charleston
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 19 ago 2026 · NCT04423211A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Carolina Urologic Research Center, Myrtle Beach
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 17 ago 2026 · NCT06842498Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Medical University of South Carolina, Charleston
In reclutamentoFase 1
Età da 18 a 100 · Uomini · Aggiornato il 13 ago 2026 · NCT05519449Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 31 lug 2026 · NCT06613100PSMA PET Combined With MRI for the Detection of PCa
- Atlantic Urology Specialists, Myrtle Beach
In reclutamentoFase 3Volontari sani benvenuti
Età 18 e oltre · Uomini · Aggiornato il 23 lug 2026 · NCT07052214Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Medical University of South Carolina, Charleston
- Levine Cancer Institute-Rock Hill, Rock Hill
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 14 lug 2026 · NCT06592924A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Carolina Urologic Research Center, the START Center for Cancer Research, Myrtle Beach
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 9 lug 2026 · NCT07103018Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
- South Texas Accelerated Research Therapeutics - Carolinas, Myrtle Beach
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 2 lug 2026 · NCT07140900International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Ralph H. Johnson VA Medical Center, Charleston
In reclutamentoStudio osservazionale
Età 21 e oltre · Uomini · Aggiornato il 22 mag 2026 · NCT03151629T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer
- Hollings Cancer Center at Medical University of South Carolina, Charleston
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 4 mar 2026 · NCT05586360Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
- Medical University of South Carolina Hollings Cancer Center, Charleston
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 5 feb 2026 · NCT07325721A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 4 feb 2026 · NCT04729114cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Medical University of South Carolina, Charleston
- McLeod Health, Florence
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età 40 e oltre · Tutti i sessi · Aggiornato il 20 gen 2026 · NCT05366881Vitamin D for Prostate Endocrine Therapy
- Gibbs Cancer Center-Gaffney, Gaffney
- Saint Francis Hospital, Greenville
- Saint Francis Cancer Center, Greenville
- e altri 3
In reclutamentoFase 3
Età 50 e oltre · Uomini · Aggiornato il 15 gen 2026 · NCT05838716A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 123, Charleston
- Research Site 108, Greenville
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 21 nov 2025 · NCT05914116SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Greenville
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 28 ott 2025 · NCT03452774Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.